News

CK Life preparing IPO

CK Life preparing IPO

CK Life Sciences International, the Chinese biotech company, is
preparing an initial public offering this week which it is hoped
will raise some HK$2.61 billion (€0.34bn) to finance future growth.

Lonza invests in production

Lonza invests in production

Switzerland's Lonza group has confirmed its commitment to the
construction of a major new production facility in the town of Visp
with the announcement of a SFr100 million (€68.4m) investment in a
biopharmaceuticals manufacturing...

Follow us

Featured Events

View more

Products

View more

Webinars